In situ localization of progesterone receptors in normal mouse mammary glands:: Absence of receptors in the connective and adipose stroma and a heterogeneous distribution in the epithelium

被引:51
作者
Shyamala, G
Barcellos-Hoff, MH
Toft, D
Yang, X
机构
[1] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA
[2] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA
关键词
D O I
10.1016/S0960-0760(97)00128-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In normal mammary glands of both rodents and humans, progesterone promotes the proliferation of epithelial cells and several lines of evidence suggest that this action of progesterone may be mediated by progesterone receptor (PR). It is well established that normal mammary development involves a complex interplay between the epithelial cells and the surrounding fatty stroma. Furthermore, during mammary development, there is a change in both the relative proportion of epithelial cells and the steady-state levels of PR. Therefore, towards understanding the precise role of PR in mammary development, we have generated a highly sensitive antibody against mouse PR and examined its pattern of localization. Immunoreactive PR was detected only in the epithelial cells of the ducts while both the adipose and fibrous stroma surrounding these ducts were receptor negative. Similarly, PR mRNA was also associated only with the ductal epithelial cells. Approximately only 45-50% of the ductal cells were receptor positive and this distribution remained unchanged whether or not the tissues had been exposed to estrogen, suggesting that they may represent a distinct subpopulation. The potential significance of these findings to mammary development is discussed. (C) 1997 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 28 条
  • [1] [Anonymous], 1988, Antibodies: A Laboratory Manual
  • [2] BERGERON C, 1988, LAB INVEST, V59, P862
  • [3] BRENNER RM, 1988, STEROID THYROID HORM, P281
  • [4] BRESCIANI FRANCESCO, 1968, CELL TISSUE KINET, V1, P51, DOI 10.1111/j.1365-2184.1968.tb00193.x
  • [5] NUCLEAR FACTOR RIP140 MODULATES TRANSCRIPTIONAL ACTIVATION BY THE ESTROGEN-RECEPTOR
    CAVAILLES, V
    DAUVOIS, S
    LHORSET, F
    LOPEZ, G
    HOARE, S
    KUSHNER, PJ
    PARKER, MG
    [J]. EMBO JOURNAL, 1995, 14 (15) : 3741 - 3751
  • [6] FAULKIN LJ, 1960, J NATL CANCER I, V24, P953
  • [7] MORPHOLOGICAL EVALUATION OF CELL TURNOVER IN RELATION TO THE MENSTRUAL-CYCLE IN THE RESTING HUMAN-BREAST
    FERGUSON, DJP
    ANDERSON, TJ
    [J]. BRITISH JOURNAL OF CANCER, 1981, 44 (02) : 177 - 181
  • [8] USE OF IMMUNOCYTOCHEMISTRY OF PROGESTERONE AND ESTROGEN-RECEPTORS FOR ENDOMETRIAL DATING
    GARCIA, E
    BOUCHARD, P
    DEBRUX, J
    BERDAH, J
    FRYDMAN, R
    SCHAISON, G
    MILGROM, E
    PERROTAPPLANAT, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) : 80 - 87
  • [9] GOING JJ, 1988, AM J PATHOL, V130, P193
  • [10] ESTROGEN RECEPTOR-ASSOCIATED PROTEINS - POSSIBLE MEDIATORS OF HORMONE-INDUCED TRANSCRIPTION
    HALACHMI, S
    MARDEN, E
    MARTIN, G
    MACKAY, H
    ABBONDANZA, C
    BROWN, M
    [J]. SCIENCE, 1994, 264 (5164) : 1455 - 1458